This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

ICAD’s VeraLook® For CT Colonography Now Available With Vital Images’ Products

iCAD, Inc. (Nasdaq: ICAD), an industry leading provider of advanced image analysis and workflow solutions for the early identification of cancer, today announced the commercial availability of iCAD’s VeraLook CTC CAD solution integrated into Vital Images’ products as a result of a strategic partnership agreement signed earlier this year. Vital Images is a Toshiba Medical Systems Group Company and the leading provider of advanced visualization and analysis solutions for healthcare providers. With this agreement, iCAD’s VeraLook CTC CAD solution is now available as part of Vital Images’ products worldwide.

This collaboration will provide clinicians with computer-aided detection (CAD) tools for the review and analysis of CT Colonography (CTC) images and will enhance the speed and accuracy of cancer detection. iCAD’s advanced image analysis technologies enable healthcare professionals to better serve patients by identifying pathologies and pinpointing the most prevalent cancers earlier. Vital Images’ scalable solutions consist of advanced visualization tools, clinical applications, and data management systems.

“The vast majority of colorectal cancer deaths are preventable with early screening, and CT Colonography has the potential to eliminate many of the traditional barriers to routine colorectal screening,” said Ken Ferry, President and CEO of iCAD. “We are enthusiastic about the broad potential of this agreement and look forward to working with Vital Images to leverage our combined powerful visualization, detection, and workflow tools to significantly improve colon cancer detection and enhance workflow for radiologists and their patients throughout the world.”

VeraLook is designed to detect and highlight potential polyps during CTC examinations. Extensive testing with radiologists has demonstrated that the use of VeraLook improved reader sensitivity to all colonic polyps in a statistically significant manner – particularly for smaller, more easily missed polyps and pre-cancerous polyps which can develop into malignancies over time. VeraLook has also demonstrated high standalone sensitivity to detecting polyps, while generating a low number of clinically acceptable false positive marks on CTC images.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,126.12 -36.87 -0.20%
S&P 500 2,120.79 -2.69 -0.13%
NASDAQ 5,097.9760 -8.6170 -0.17%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs